GDF15, due to its sensitivity to metabolic signals and its function in inhibiting tumor-promoting stromal dynamics, presents a valuable molecular target for comprehensive therapeutic approaches, especially in individuals with metabolic comorbidities like diabetes [102]. This evidence concerns the gene GDF15 and diabetes mellitus.